BFRI
Biofrontera·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
BFRI fundamentals
Biofrontera (BFRI) released its earnings on Nov 12, 2025: revenue was 6.99M (YoY -22.46%), missed estimates; EPS was -0.62 (YoY +36.73%), missed estimates.
Revenue / YoY
6.99M
-22.46%
EPS / YoY
-0.62
+36.73%
Report date
Nov 12, 2025
BFRI Earnings Call Summary for Q3,2025
- Resilient Revenue Performance: Flat YTD despite no price increase, Q3 down 22% due to one-time 2024 stockpiling.
- Strategic Cost Optimization: 58% cost of sales reduction via royalty agreement, $11M investor financing.
- Pipeline Momentum: 750+ RhodoLED lamps installed, FDA expansion for BCC in Q4 2026, acne Phase II data expected early 2026.
- Liquidity Strengthening: $3.4M cash + $5.5M new proceeds, targeting 2026 cash flow breakeven.
EPS
Revenue
Revenue & Expenses
BFRI has released its 2025 Q3 earnings report, with revenue of 6.99M, reflecting a YoY change of -22.46%, and net profit of -6.65M, showing a YoY change of -17.29%. The Sankey diagram below clearly presents BFRI's revenue sources and cost distribution.
Key Indicators
Biofrontera (BFRI) key financial stats and ratios, covering profitability, financial health, and leverage.
Biofrontera (BFRI)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Biofrontera (BFRI)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Biofrontera (BFRI)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Biofrontera (BFRI) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Biofrontera (BFRI) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What is the revenue and EPS growth rate for Biofrontera year over year?What is the market's earnings forecast for Biofrontera next quarter?Did Biofrontera beat or miss consensus estimates last quarter?What is Biofrontera's latest dividend and current dividend yield?What guidance did Biofrontera's management provide for the next earnings period?What factors drove the changes in Biofrontera's revenue and profit?What does Biofrontera do and what are its main business segments?What were the key takeaways from Biofrontera's earnings call?
